S

Sientra Inc
F:S0Z

Watchlist Manager
Sientra Inc
F:S0Z
Watchlist
Price: 1.302 EUR -3.41% Market Closed
Market Cap: €206.4m

Gross Margin

42.1%
Current
Declining
by 1.4%
vs 3-y average of 43.5%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
42.1%
=
Gross Profit
$38m
/
Revenue
$90.3m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
42.1%
=
Gross Profit
€38m
/
Revenue
$90.3m

Peer Comparison

Country Company Market Cap Gross
Margin
US
Sientra Inc
F:S0Z
206.4m EUR
Loading...
US
Medline Inc
NASDAQ:MDLN
65.2B USD
Loading...
JP
Hoya Corp
TSE:7741
9.8T JPY
Loading...
CH
Alcon AG
SIX:ALC
32.3B CHF
Loading...
DK
Coloplast A/S
CSE:COLO B
111.4B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
13.2B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
5.2B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.5B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.1B CNY
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
833.6B JPY
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
49th
Based on 12 729 companies
49th percentile
42.1%
Low
-24 813% — 28.9%
Typical Range
28.9% — 60.5%
High
60.5% — 10 905 714.3%
Distribution Statistics
the United States of America
Min -24 813%
30th Percentile 28.9%
Median 43%
70th Percentile 60.5%
Max 10 905 714.3%

Sientra Inc
Glance View

Market Cap
206.4m EUR
Industry
Health Care

Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Santa Barbara, California and currently employs 319 full-time employees. The company went IPO on 2014-10-29. The firm's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The firm sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The firm also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.

S0Z Intrinsic Value
Not Available
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
42.1%
=
Gross Profit
$38m
/
Revenue
$90.3m
What is Sientra Inc's current Gross Margin?

The current Gross Margin for Sientra Inc is 42.1%, which is below its 3-year median of 43.5%.

How has Gross Margin changed over time?

Over the last 3 years, Sientra Inc’s Gross Margin has decreased from 58.8% to 42.1%. During this period, it reached a low of 42.1% on Sep 30, 2023 and a high of 58.8% on Sep 30, 2020.

Back to Top